Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Eran Shavit; Afsaneh Alavi; Falk G Bechara; Richard G Bennett; Marc Bourcier; Ricardo Cibotti; Steven Daveluy; John W Frew; Amit Garg; Iltefat Hamzavi; Lauren K Hoffman; Jenny Hsaio; Joslyn Sciacca Kirby; Hadar Lev-Tov; Erin Martinez; Robert Micheletti; Haley B Naik; Aude Nassif; Cynthia Nicholson; Angie Parks-Miller; Zarine Patel; Vincent Piguet; Mayur Ramesh; Barry Resnik; Christopher Sayed; Gregory Schultz; Aamir Siddiqui; Jerry Tan; Ximena Wortsman; Michelle A Lowes

doi:10.1111/exd.13849

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017

Exp Dermatol. 2019 Jan;28(1):94-103. doi: 10.1111/exd.13849.

Authors

Eran Shavit¹, Afsaneh Alavi¹, Falk G Bechara², Richard G Bennett³, Marc Bourcier⁴, Ricardo Cibotti⁵, Steven Daveluy⁶, John W Frew⁷, Amit Garg⁸, Iltefat Hamzavi⁹, Lauren K Hoffman¹⁰, Jenny Hsaio¹¹, Joslyn Sciacca Kirby¹², Hadar Lev-Tov¹³, Erin Martinez¹⁴, Robert Micheletti¹⁵, Haley B Naik¹⁶, Aude Nassif¹⁷, Cynthia Nicholson¹⁸, Angie Parks-Miller^{2

19}, Zarine Patel^{10

20}, Vincent Piguet¹, Mayur Ramesh²¹, Barry Resnik¹³, Christopher Sayed²², Gregory Schultz²³, Aamir Siddiqui²⁴, Jerry Tan²⁵, Ximena Wortsman^{26

27}, Michelle A Lowes²⁸

Affiliations

¹ Department of Medicine, Division of Dermatology, Women College Hospital, University of Toronto, Toronto, Ontario, Canada.
² Department of Dermatology, Dermatologic Surgery Unit, Ruhr-University Bochum, Bochum, Germany.
³ Department of Dermatology, University of California, Los Angeles, Los Angeles, California.
⁴ Dermatology Clinic, Sherbrooke University, Moncton, New Brunswick, Canada.
⁵ National Institute of Arthritis and Musculoskeletal and skin diseases, National Institute of Health, Bethesda, Maryland.
⁶ Department of Dermatology, Wayne State University, Dearborn, Michigan.
⁷ Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.
⁸ Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York.
⁹ Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
¹⁰ Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
¹¹ Ronald Reagan UCLA Medical Center, Santa Monica, California.
¹² Department of Dermatology, Pennsylvania State, Hershey, Pennsylvania.
¹³ Department of Dermatology & Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida.
¹⁴ School of Social Work, Detroit, Michigan.
¹⁵ Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁶ Department of Dermatology, UCSF School of Medicine, San Francisco, California.
¹⁷ Institut Pasteur, Centre Medical, Paris, France.
¹⁸ Department of Dermatology, Wayne State University, Detroit, Michigan.
¹⁹ Clinical Research Manager, Henry Ford Hospital, Detroit, Michigan.
²⁰ Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York.
²¹ Department of Internal Medicine/Infectious Diseases, Henry Ford Hospital, Detroit, Michigan.
²² Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
²³ Institute of Wound Research, University of Florida, Gainesville, Florida.
²⁴ Department of Plastic Surgery, Henry Ford Hospital, Detroit, Michigan.
²⁵ Department of Medicine, University of Western Ontario, Windsor, Ontario, Canada.
²⁶ Department of Dermatology, Institute for Diagnostic Imaging and Research of the Skin and Soft Tissues, University of Chile, Santiago, Chile.
²⁷ Department of Dermatology, Pontifical Catholic University, Santiago, Chile.
²⁸ The Rockefeller University, New York City, New York.

Abstract

The 2nd Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) took place on 03-05 November 2017 in Detroit, Michigan, USA. This symposium was a joint meeting of the Hidradenitis Suppurativa Foundation (HSF Inc.) founded in the USA, and the Canadian Hidradenitis Suppurativa Foundation (CHSF). This was the second annual meeting of the SHSA with experts from different disciplines arriving from North America, Europe and Australia, in a joint aim to discuss most recent innovations, practical challenges and potential solutions to issues related in the management and care of Hidradenitis Suppurativa patients. The last session involved clinicians, patients and their families in an effort to educate them more about the disease.

Keywords: hidradenitis suppurativa; symposium.

Publication types

Congress

MeSH terms

Anti-Infective Agents / therapeutic use*
Anti-Inflammatory Agents / therapeutic use
Biomedical Research
Comorbidity
Dermatologic Surgical Procedures*
Hidradenitis Suppurativa / diagnostic imaging
Hidradenitis Suppurativa / epidemiology
Hidradenitis Suppurativa / etiology*
Hidradenitis Suppurativa / therapy*
Humans
Incidence
Quality of Life
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Ultrasonography

Substances

Anti-Infective Agents
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha

Grants and funding

R13 AR074881/AR/NIAMS NIH HHS/United States